Lv7
5000 积分 2022-10-31 加入
Emerging innovative immunotherapies in malignant ascites: current landscape, challenges and perspectives
19天前
已完结
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
1个月前
已完结
The dual role of the CXCL9/10/11-CXCR3 axis in the tumor immune microenvironment: Mechanisms, therapeutic implications, and clinical translation
1个月前
已完结
The dual role of the CXCL9/10/11-CXCR3 axis in the tumor immune microenvironment: Mechanisms, therapeutic implications, and clinical translation
4个月前
已关闭
TREM2+ macrophages suppress CD8+ T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma
6个月前
已完结
Targeting HSPB1 Inhibits Tumor Growth and Abrogates Treg-Mediated Tumor Immunosuppression
6个月前
已关闭
Discovery of a Novel CSF-1R Inhibitor with Highly Improved Pharmacokinetic Profiles and Superior Efficacy in Colorectal Cancer Immunotherapy
7个月前
已完结
Interleukin-11: A Central Integrative Hub Driving Pathological Progression from Pulmonary Inflammation and Fibrosis to Cancer
10个月前
已完结
Asia’s accelerating burden of early-onset pancreatic cancer: a 32-year global comparative analysis using GBD 2021
11个月前
已完结
CX3CL1: a key switch of cell death immunogenicity
11个月前
已完结
皖公网安备34019202002308
